This study aimed to compare the cost and outcomes of robotic transhiatal esophagectomy (THE) with "non-robotic" approaches, including open and laparoscopic procedures. The researchers prospectively followed 82 patients who underwent THE and analyzed clinical outcomes and perioperative charges. Of these, 67 patients had the robotic approach, and 15 had "non-robotic" procedures (4 open and 11 laparoscopic). Most patients had adenocarcinoma of the esophagus. 

The results showed that the robotic approach had a longer operative duration but minimal blood loss compared to "non-robotic" methods. However, there were no significant differences in the length of hospital stay between the two groups. Around 15% of robotic operations and 13% of "non-robotic" operations were profitable. 

Overall, the study suggests that the robotic approach for THE has comparable charges, costs, and profitability to "non-robotic" approaches. The findings indicate that the robotic procedure is feasible and safe for esophageal cancer patients and may be a suitable alternative to traditional methods in specific cases.